PodcastRx with Chris Bender: December 2024

Topic

News

A Pharmacist's Holiday Wish List

With our hosts in a holiday mood and 2024 hurtling to a close, Chris reflects on the clinical, professional, and regulatory wants and wishes he'd like to see come true in 2025. We cover:

Potential drug approvals
Provider status for pharmacists
Biosimilar substitution
Relieving drug shortages
A brief digression on Wegovy vs. Zepbound

‍

Before that, Chris highlights the expanded approval of Bimzelx for hideranitis supportiva and breaks down updated guidelines related to COPD and Restless Leg Syndrome.

‍

And for the ending Trivia Capsule segment, Chris makes a light-hearted (if tenuous) connection between the "Rudolph the Red-Nosed Reindeer" TV special and the medicinal benefits of the two most precious metals (medals?).

‍

Listen here or where you enjoy podcasts! And please rate and/or review the show!

‍

Links to Material Discussed in Each Segment:

‍

"Into the Clinic"

Bimekizumab: A Promising Option for Moderate to Severe Hidradenitis Suppurativa

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

FDA approves Novartis Cosentyx® as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade

Bimzelx: Highlights of Prescribing Information

GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD: 2025 Report

New guideline provides treatment recommendations for restless legs syndrome